SFS
RETA

Sowell Financial Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Sowell Financial Services’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80
Closed -$7K – 2969
2021
Q1 		$7K Sell
80
-4
-5% -$467 ﹤0.01% 2495
2020
Q4 		$10K Buy
84
+66
+367% +$8.67K ﹤0.01% 2033
2020
Q3 		$2K Sell
18
-14
-44% -$1.75K ﹤0.01% 2296
2020
Q2 		$5K Buy
+32
New +$4.87K ﹤0.01% 1927

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Sowell Financial Services's RETA Position: Q2 2021 in Review

Sowell Financial Services sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2021, closing a stake of 80 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in RETA in Q2 2020 and held it in 4 quarters. The position peaked at $10K in Q4 2020. 194 funds tracked by Wall St. Rank hold RETA as of Q2 2021.

  • Sowell Financial Services reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 80 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2021, an estimated $7K.
  • Sowell Financial Services first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2020 and held it in 4 quarters.
  • Sowell Financial Services's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $10K in Q4 2020.
  • 194 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.